| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.015 | 0.8 |